ESR1 and breast carcinoma: In the present work, we demonstrate that inducibly silencing the glycerophosphodiesterase EDI3 in ER-HER2+ HCC1954 breast cancer cells reduces the tumor burden subsequent to tail vein or intraperitoneal tumor cell injection using in vivo luminescence imaging in two mouse models of experimental metastasis.